Description
SWOT ANALYSIS OF GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

GlaxoSmithKline Pharmaceuticals Ltd.

Parent Company

GlaxoSmithKline Plc

Category

pharmaceutical and healthcare companies

Sector

Health Care

Tagline/ Slogan

Do more, feel better, live longer

GlaxoSmithKline is the UK’s largest and world’s second largest USP pharmaceutical company

STP

Segment

Consumer healthcare, prescription medicines & vaccines

Patients & healthcare professionals seeking detection, prevention & Target Group treatment of disease.

Positioning

We are science led global healthcare company

SWOT Analysis

1. GSK is one of the top 5 largest pharmaceutical companies. 2.GSK is one of the world’s largest investor in R&D and UK's biggest private sector funder of R&D. 3. Winner of chemical industry manufacturing and resource efficiency award. 4. Strong R&D focus and exploring new markets 5. GSK is a global presence is in over 100 countries Strength 6. Has a strength of over 97000 employees

1. Controversies regarding issue of safety of drugs affects company’s image Weakness 2. Patent expiry for a number of bulk-buster products

1.Strategic agreements with other pharmaceutical companies and organizations to boost its research. 2. Increasing awareness about healthcare needs 3. Global penetration through mergers and acquisitions Opportunity 4. Increasing demand for quality healthcare solutions

1.Risk of unsuccessful new Products 2.Regulatory environment is becoming more & more stringent Threats 3.Economic slowdown in European markets

Competition

1. Abbott Laboratories 2. Amgen 3. AstraZeneca 4. Bristol-Myers Squibb 5. Johnson & Johnson 6. Merck 7. Novartis 8. P?zer 9. Roche Holdings Competitors 10. Sun Pharma



doc_940543492.docx
 

Attachments

Back
Top